Zum Inhalt

Clinical Pharmacokinetics

Ausgabe 2/2025

Inhalt (10 Artikel)

Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis

  • Open Access
  • Systematic Review

K. V. van der Heijden, M. E. Otto, J. W. Schoones, M. J. van Esdonk, L. G. J. M. Borghans, J. G. C. van Hasselt, J. M. A. van Gerven, G. Jacobs

Population Pharmacokinetics of Meropenem Across the Adult Lifespan

  • Original Research Article

Angelique E. Boutzoukas, Stephen J. Balevic, Marion Hemmersbach-Miller, Patricia L. Winokur, Kenan Gu, Austin W. Chan, Michael Cohen-Wolkowiez, Thomas Conrad, Guohua An, Carl M. J. Kirkpatrick, Geeta K. Swamy, Emmanuel B. Walter, Kenneth E. Schmader, Cornelia B. Landersdorfer

Dose Optimization of Vancomycin in Pediatric Post-Cardiac Surgery Patients: A Population Pharmacokinetic Modeling Study

  • Original Research Article

J. Kamp, D. J. E. Wannet, E. P. Buddingh, J. van Prehn, H. E. Bunker-Wiersma, J. J. van Wattum, R. H. Klein, P. P. Roeleveld, D. J. A. R. Moes

Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function

  • Original Research Article

Fatima Zbib, Anthéa Deschamps, Lionel Velly, Olivier Blin, Romain Guilhaumou, Florence Gattacceca

Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling

  • Open Access
  • Original Research Article

Frédéric Gaspar, Celestin Jacost-Descombes, Pauline Gosselin, Jean-Luc Reny, Monia Guidi, Chantal Csajka, Caroline Samer, Youssef Daali, Jean Terrier

Population Pharmacokinetics of Telmisartan in Healthy Subjects and Hypertensive Patients

  • Original Research Article

In Hwan Jeong, Sooyoon Ryu, Nayoung Han, Christine E. Staatz, In-hwan Baek

Identifying the Optimal Sampling Strategy for the Bayesian Estimation of Vancomycin AUC0–24 in Adult Hematologic Cancer Patients

  • Original Research Article

Alexandre Duong, Jessica Le Blanc, Denis Projean, Amélie Marsot

Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis

  • Original Research Article

Celine Konecki, Mark L. Lipman, Thomas A. Mavrakanas, Zoubir Djerada